BDRX logo

Biodexa Pharmaceuticals Plc

BDRX
Healthcare|Biotechnology|GB
$2.48
+0.07 (+2.88%)
DCF Value
$0.42
Tangible Book / Share
$0.19
Cash / Share
$0.17
Next Earnings Report
Apr 23, 2027
Financing Filings (last 12 months)
69
Shelf registrations / offering prospectuses — latest Oct 14, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (1)

Jul 2030
Est. completion
P3Familial Adenomatous Polyposis (FAP)
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
NCT06950385n=168

Recent Press Releases

Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP
Oct 13, 2026 · GlobeNewsWire
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
Sep 23, 2026 · Accesswire
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds
Sep 15, 2026 · GlobeNewsWire
Interim results for the six months ended June 30, 2026
Sep 11, 2026 · GlobeNewsWire
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
Aug 19, 2026 · GlobeNewsWire

SEC Filings (211)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 14, 20266-KForeign issuer reportDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 14, 2026424B3Offering prospectusDocumentIndex
Oct 8, 20266-KForeign issuer reportDocumentIndex
Oct 6, 2026424B3Offering prospectusDocumentIndex
Sep 30, 2026EFFECTDocumentIndex
Sep 24, 2026F-1IPO / offering registrationDocumentIndex
Sep 15, 2026424B3Offering prospectusDocumentIndex
Sep 15, 2026424B3Offering prospectusDocumentIndex
Sep 15, 2026424B3Offering prospectusDocumentIndex
Sep 15, 2026424B3Offering prospectusDocumentIndex
Sep 15, 2026424B3Offering prospectusDocumentIndex
Sep 15, 2026424B3Offering prospectusDocumentIndex
Sep 15, 2026424B3Offering prospectusDocumentIndex
Sep 15, 20266-KForeign issuer reportDocumentIndex
Sep 11, 2026424B3Offering prospectusDocumentIndex
Sep 11, 2026424B3Offering prospectusDocumentIndex
Sep 11, 2026424B3Offering prospectusDocumentIndex
Sep 11, 2026424B3Offering prospectusDocumentIndex
Sep 11, 2026424B3Offering prospectusDocumentIndex
Sep 11, 2026424B3Offering prospectusDocumentIndex
Sep 11, 2026424B3Offering prospectusDocumentIndex
Sep 11, 20266-KForeign issuer reportDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 5, 2026424B3Offering prospectusDocumentIndex
Aug 5, 2026424B3Offering prospectusDocumentIndex
Aug 5, 2026424B3Offering prospectusDocumentIndex
Aug 5, 2026424B3Offering prospectusDocumentIndex
Aug 5, 2026424B3Offering prospectusDocumentIndex
Aug 5, 2026424B3Offering prospectusDocumentIndex
Aug 4, 2026424B3Offering prospectusDocumentIndex
Aug 3, 2026EFFECTDocumentIndex
Jul 30, 2026F-1/AIPO / offering registrationDocumentIndex
Jul 29, 20266-KForeign issuer reportDocumentIndex